The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
STORY German pharmaceutical company sees great benefits from CIIE spillover effectSHOOTING TIME Recent footageDATELINE Nov 10 2024LENGTH 00011 ...
German drugmaker Boehringer Ingelheim has its first regulatory approval ... The FDA has cleared the IL-36 receptor inhibitor under the Spevigo brand name to treat the devastating eruptions of ...
Boehringer Ingelheim has halted development of an obesity drug from Gubra that it originally pledged to advance back in 2017, ...
The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals ...
A new survey shows that three Big Pharmas have stolen the hearts of patient groups representing nearly 1 million people with cardiovascular conditions. | A new survey shows that three Big Pharmas have ...
Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...
Greater awareness of – and engagement around – the Boehringer Ingelheim brand. Facebook friends and family of everyone who tries out the game will potentially be exposed to it, while media ...
Privately-held German drugmaker Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the ...
With a capital investment of US$66.1 million and 63 new jobs created, this expansion includes the addition of 63,000 square feet of administrative space and more than 28,000 square feet of laboratory ...
U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales into researching and developing products that will advance the health of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback